144 related articles for article (PubMed ID: 34861246)
41. A mechanistic study of the proapoptotic effect of tolfenamic acid: involvement of NF-κB activation.
Jeong JB; Yang X; Clark R; Choi J; Baek SJ; Lee SH
Carcinogenesis; 2013 Oct; 34(10):2350-60. PubMed ID: 23784084
[TBL] [Abstract][Full Text] [Related]
42. Cryptopleurine targets NF-κB pathway, leading to inhibition of gene products associated with cell survival, proliferation, invasion, and angiogenesis.
Jin HR; Jin SZ; Cai XF; Li D; Wu X; Nan JX; Lee JJ; Jin X
PLoS One; 2012; 7(6):e40355. PubMed ID: 22768286
[TBL] [Abstract][Full Text] [Related]
43. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
Tse AK; Wan CK; Shen XL; Yang M; Fong WF
Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
[TBL] [Abstract][Full Text] [Related]
44. Luteolin, a novel p90 ribosomal S6 kinase inhibitor, suppresses proliferation and migration in leukemia cells.
Deng L; Jiang L; Lin X; Tseng KF; Lu Z; Wang X
Oncol Lett; 2017 Mar; 13(3):1370-1378. PubMed ID: 28454264
[TBL] [Abstract][Full Text] [Related]
45. Benzisothiazolone Derivatives Exhibit Cytotoxicity in Hodgkin's Lymphoma Cells through NF-κB Inhibition and are Synergistic with Doxorubicin and Etoposide.
Nandakumar N; Gopinath P; Gopas J; Muraleedharan KM
Anticancer Agents Med Chem; 2020; 20(6):715-723. PubMed ID: 32053083
[TBL] [Abstract][Full Text] [Related]
46. A-kinase-interacting protein 1 (AKIP1) acts as a molecular determinant of PKA in NF-kappaB signaling.
Gao N; Hibi Y; Cueno M; Asamitsu K; Okamoto T
J Biol Chem; 2010 Sep; 285(36):28097-104. PubMed ID: 20562110
[TBL] [Abstract][Full Text] [Related]
47. The N terminus of orf virus-encoded protein 002 inhibits acetylation of NF-κB p65 by preventing Ser(276) phosphorylation.
Ning Z; Zheng Z; Hao W; Duan C; Li W; Wang Y; Li M; Luo S
PLoS One; 2013; 8(3):e58854. PubMed ID: 23536830
[TBL] [Abstract][Full Text] [Related]
48. Combined effects of histone deacetylase inhibitor and rituximab on non-Hodgkin's B-lymphoma cells apoptosis.
Zhao WL; Wang L; Liu YH; Yan JS; Leboeuf C; Liu YY; Wu WL; Janin A; Chen Z; Chen SJ
Exp Hematol; 2007 Dec; 35(12):1801-11. PubMed ID: 17681667
[TBL] [Abstract][Full Text] [Related]
49. The p90 ribosomal S6 kinase (RSK) inhibitor BI-D1870 prevents gamma irradiation-induced apoptosis and mediates senescence via RSK- and p53-independent accumulation of p21WAF1/CIP1.
Neise D; Sohn D; Stefanski A; Goto H; Inagaki M; Wesselborg S; Budach W; Stühler K; Jänicke RU
Cell Death Dis; 2013 Oct; 4(10):e859. PubMed ID: 24136223
[TBL] [Abstract][Full Text] [Related]
50. Extracellular signal-regulated kinase/90-KDA ribosomal S6 kinase/nuclear factor-kappa B pathway mediates phorbol 12-myristate 13-acetate-induced megakaryocytic differentiation of K562 cells.
Kim KW; Kim SH; Lee EY; Kim ND; Kang HS; Kim HD; Chung BS; Kang CD
J Biol Chem; 2001 Apr; 276(16):13186-91. PubMed ID: 11278385
[TBL] [Abstract][Full Text] [Related]
51. Thrombin-induced CCAAT/enhancer-binding protein β activation and IL-8/CXCL8 expression via MEKK1, ERK, and p90 ribosomal S6 kinase 1 in lung epithelial cells.
Lin CH; Nai PL; Bien MY; Yu CC; Chen BC
J Immunol; 2014 Jan; 192(1):338-48. PubMed ID: 24277696
[TBL] [Abstract][Full Text] [Related]
52. The serine-threonine kinase p90RSK is a new target of enzastaurin in follicular lymphoma cells.
Kheirallah S; Fruchon S; Ysebaert L; Blanc A; Capilla F; Marrot A; Alsaati T; Frenois FX; Benhadji KA; Fournié JJ; Laurent G; Bezombes C
Br J Pharmacol; 2013 Dec; 170(7):1374-83. PubMed ID: 23992368
[TBL] [Abstract][Full Text] [Related]
53. Anti-tumoral effect of arsenic compound, sodium metaarsenite (KML001), in non-Hodgkin's lymphoma: an in vitro and in vivo study.
Yoon JS; Hwang DW; Kim ES; Kim JS; Kim S; Chung HJ; Lee SK; Yi JH; Uhm J; Won YW; Park BB; Choi JH; Lee YY
Invest New Drugs; 2016 Feb; 34(1):1-14. PubMed ID: 26581399
[TBL] [Abstract][Full Text] [Related]
54. Mitogen- and stress-activated kinase 1 (MSK1) regulates cigarette smoke-induced histone modifications on NF-κB-dependent genes.
Sundar IK; Chung S; Hwang JW; Lapek JD; Bulger M; Friedman AE; Yao H; Davie JR; Rahman I
PLoS One; 2012; 7(2):e31378. PubMed ID: 22312446
[TBL] [Abstract][Full Text] [Related]
55. Tenascin-C induces resistance to apoptosis in pancreatic cancer cell through activation of ERK/NF-κB pathway.
Shi M; He X; Wei W; Wang J; Zhang T; Shen X
Apoptosis; 2015 Jun; 20(6):843-57. PubMed ID: 25690319
[TBL] [Abstract][Full Text] [Related]
56. I-kappa-kinase-2 (IKK-2) inhibition potentiates vincristine cytotoxicity in non-Hodgkin's lymphoma.
Al-Katib A; Arnold AA; Aboukameel A; Sosin A; Smith P; Mohamed AN; Beck FW; Mohammad RM
Mol Cancer; 2010 Sep; 9():228. PubMed ID: 20809973
[TBL] [Abstract][Full Text] [Related]
57. Novel changes in NF-{kappa}B activity during progression and regression phases of hyperplasia: role of MEK, ERK, and p38.
Chandrakesan P; Ahmed I; Anwar T; Wang Y; Sarkar S; Singh P; Peleg S; Umar S
J Biol Chem; 2010 Oct; 285(43):33485-33498. PubMed ID: 20710027
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of Oncogenic Transcription Factor REL by the Natural Product Derivative Calafianin Monomer 101 Induces Proliferation Arrest and Apoptosis in Human B-Lymphoma Cell Lines.
Yeo AT; Chennamadhavuni S; Whitty A; Porco JA; Gilmore TD
Molecules; 2015 Apr; 20(5):7474-94. PubMed ID: 25915462
[TBL] [Abstract][Full Text] [Related]
59. Neurotrophin signaling through tropomyosin receptor kinases contributes to survival and proliferation of non-Hodgkin lymphoma.
Sniderhan LF; Garcia-Bates TM; Burgart M; Bernstein SH; Phipps RP; Maggirwar SB
Exp Hematol; 2009 Nov; 37(11):1295-309. PubMed ID: 19716854
[TBL] [Abstract][Full Text] [Related]
60. Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits.
Hao J; Fan W; Li Y; Tang R; Tian C; Yang Q; Zhu T; Diao C; Hu S; Chen M; Guo P; Long Q; Zhang C; Qin G; Yu W; Chen M; Li L; Qin L; Wang J; Zhang X; Ren Y; Zhou P; Zou L; Jiang K; Guo W; Deng W
J Exp Clin Cancer Res; 2019 Feb; 38(1):48. PubMed ID: 30717768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
